Publication: Minimal dose and time protection by lindane (γ‐isomer of 1,2,3,4,5,6 hexachlorocyclohexane) against liver tumors induced by aflatoxin b<inf>1</inf>
Issued Date
1989-01-01
Resource Type
ISSN
10970215
00207136
00207136
Other identifier(s)
2-s2.0-0024553113
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of Cancer. Vol.43, No.3 (1989), 531-534
Suggested Citation
Subhkij Angsubhakorn, Natth Bhamarapravati, Apichat Pradermwong, Nipa Im‐Emgamol, Somphong Sahaphong Minimal dose and time protection by lindane (γ‐isomer of 1,2,3,4,5,6 hexachlorocyclohexane) against liver tumors induced by aflatoxin b<inf>1</inf>. International Journal of Cancer. Vol.43, No.3 (1989), 531-534. doi:10.1002/ijc.2910430332 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/15729
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Minimal dose and time protection by lindane (γ‐isomer of 1,2,3,4,5,6 hexachlorocyclohexane) against liver tumors induced by aflatoxin b<inf>1</inf>
Other Contributor(s)
Abstract
This study was carried out in order to investigate the minimal exposure to lindane (LD, 99.72% gamma isomer of 1,2,3,4,5,6 hexachlorocyclohexane), a chlorinated hydrocarbon insecticide, required to protect against liver tumor induced by aflatoxin B 1 (AFB 1 ). Materials fed to Buffalo strain rats were as follows: LD 100 ppm; AFB 1 I ppm, LD 100 ppm plus AFB 1 1 ppm; and control basal diet. The experimental animals were clinically observed and then serially killed at 1, 3, 5, 10, 15 and 82 weeks. Concurrent administration of LD with AFB 1 to rats for more than 3 weeks totally inhibited the incidence of AFB 1 ‐induced hepatocellular carcinomas by week 82. Only 1 of 20 rats (5%) fed the same regimen for 1 week developed liver tumors. Animals given 1 ppm AFB 1 singly for 15 weeks had a high liver tumor incidence (31.5%). No animals developed liver tumors in LD‐treated and control groups. LD may inhibit AFB 1 ‐induced liver tumors by stimulating hepatic metabolism and excretion of AFB 1 so that less carcinogen is available to liver tissue. Copyright © 1989 Wiley‐Liss, Inc., A Wiley Company